739 results on '"Toniutto, Pierluigi"'
Search Results
2. Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis
3. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
4. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
5. Real-world experience with long-term albumin in patients with cirrhosis and ascites
6. Trends in liver transplantation for primary sclerosing cholangitis
7. Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
8. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
9. Evaluation Process of the Liver Transplant Recipient
10. SAT-007-YI Assessing sex differences in access to liver transplantation in Italy: a real-world nationwide study
11. FRI-078-YI Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database
12. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
13. FRI-047-YI Predictors of ascites resolution in patients with cirrhosis receiving long-term albumin treatment. Results from a real-world study in Italy (Real-ANSWER)
14. WED-414 Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)
15. THU-092 Enrolling patients in ACLF trials-the need to increase ACLF awareness (DHELIVER trial)
16. Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience
17. Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study
18. The Equitable Benefit Approach to guide the assessment of medical and psychosocial factors in liver transplant candidacy.
19. An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know
20. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort
21. Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis
22. New Therapies of Liver Diseases.
23. Trends in liver transplantation for primary sclerosing cholangitis.
24. Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review
25. Biologikatherapie der Psoriasis in organtransplantierten Patienten
26. HepaDisk – A new quality of life questionnaire for HCV patients
27. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
28. AISF position paper on HCV in immunocompromised patients
29. Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review.
30. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients
31. Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
32. NTCP genetic variants may influence early virological response to bulevirtide monotherapy in patients with HDV related cirrhosis
33. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
34. Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy
35. Real-word experience of long-term albumin treatment in a large cohort of patients with cirrhosis and ascites (Real-Answer study)
36. Unexpected high incidence of AMA positive primary biliary cholangitis in a northern Italian region
37. ACLF course profiles over screening period in the phase IIb DHELIVER study
38. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
39. Common issues in the management of patients in the waiting list and after liver transplantation
40. Consensus conference on TIPS management: Techniques, indications, contraindications
41. Biologic treatment of psoriasis in solid organ transplant recipients.
42. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis
43. Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience
44. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
45. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
46. Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant
47. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis
48. Vascular liver diseases: A sex-oriented analysis of the literature
49. Complete Endovascular Stenting of the Inferior Vena Cava Following Its Twisting After Liver Transplantation
50. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.